47.06
price down icon7.91%   -4.04
after-market Handel nachbörslich: 47.10 0.04 +0.08%
loading

Harrow Inc Aktie (HROW) Neueste Nachrichten

pulisher
Dec 11, 2025

Harrow Health stock hits 52-week high at 50.75 USD - Investing.com

Dec 11, 2025
pulisher
Dec 09, 2025

Precision Trading with Harrow Health Inc. 11.875% Senior Notes Due 2027 (HROWM) Risk Zones - news.stocktradersdaily.com

Dec 09, 2025
pulisher
Dec 08, 2025

Divisadero Street Capital Management LP Takes Position in Harrow, Inc. $HROW - MarketBeat

Dec 08, 2025
pulisher
Dec 07, 2025

Aug Closing: Why Harrow Inc stock is favored by pension funds2025 Performance Recap & Daily Entry Point Trade Alerts - moha.gov.vn

Dec 07, 2025
pulisher
Dec 06, 2025

Harrow (HROW) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 06, 2025
pulisher
Dec 06, 2025

How the Narrative Surrounding Harrow Is Evolving After Analyst Target Upgrades - Yahoo Finance

Dec 06, 2025
pulisher
Dec 05, 2025

Can Harrow Inc. stock deliver strong Q4 earningsLong Setup & Safe Capital Growth Stock Tips - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Panagora Asset Management Inc. Acquires Shares of 47,132 Harrow, Inc. $HROW - MarketBeat

Dec 05, 2025
pulisher
Dec 05, 2025

155,465 Shares in Harrow, Inc. $HROW Acquired by Diametric Capital LP - MarketBeat

Dec 05, 2025
pulisher
Dec 04, 2025

Harrow (NASDAQ:HROW) Shares Up 10.2%Time to Buy? - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

Harrow, Inc. (NASDAQ:HROW) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Dec 04, 2025
pulisher
Dec 03, 2025

How CVS Elevating Vevye To Tier 1 Coverage At Harrow (HROW) Has Changed Its Investment Story - Yahoo Finance

Dec 03, 2025
pulisher
Dec 02, 2025

Should Vevye’s CVS Formulary Win Prompt a Closer Look from Harrow (HROW) Investors? - simplywall.st

Dec 02, 2025
pulisher
Dec 01, 2025

Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS (NASDAQ:HROW) - Seeking Alpha

Dec 01, 2025
pulisher
Dec 01, 2025

Creative Planning Grows Holdings in Harrow, Inc. $HROW - MarketBeat

Dec 01, 2025
pulisher
Nov 30, 2025

Harrow, Inc. $HROW Shares Purchased by Geode Capital Management LLC - MarketBeat

Nov 30, 2025
pulisher
Nov 30, 2025

Intech Investment Management LLC Sells 6,798 Shares of Harrow, Inc. $HROW - MarketBeat

Nov 30, 2025
pulisher
Nov 29, 2025

Insider Sell: Why Harrow Inc. stock appeals to dividend seekersMarket Trend Review & Weekly High Return Stock Opportunities - moha.gov.vn

Nov 29, 2025
pulisher
Nov 28, 2025

Market Trends: Is Harrow Inc. stock attractive for income investors - moha.gov.vn

Nov 28, 2025
pulisher
Nov 28, 2025

How Harrow Health Inc. 8.625% Senior Notes Due 2026 (HROWL) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Nov 28, 2025
pulisher
Nov 28, 2025

Harrow to Present at Two Investor Conferences in December - Sahm

Nov 28, 2025
pulisher
Nov 28, 2025

Following a 2.8% Decline Over Last Year, Recent Gains May Please Harrow, Inc. (NASDAQ:HROW) Institutional Owners - 富途牛牛

Nov 28, 2025
pulisher
Nov 27, 2025

Is Harrow Inc. stock attractive for income investorsBull Run & Daily Chart Pattern Signal Reports - moha.gov.vn

Nov 27, 2025
pulisher
Nov 27, 2025

Private Equity-Style Fund Buys $15.7 Million in Harrow Stock as Revenue Jumps 45% - Yahoo Finance

Nov 27, 2025
pulisher
Nov 27, 2025

Penn Capital Unwinds $17.1 Million BGC Stake as Broker Posts 31% Revenue Surge - The Motley Fool

Nov 27, 2025
pulisher
Nov 25, 2025

A Fresh Look at Harrow (HROW) Valuation Following Recent Revenue Growth and Long-Term Performance - Yahoo Finance

Nov 25, 2025
pulisher
Nov 21, 2025

Why Harrow Inc. stock remains on watchlistsJuly 2025 WrapUp & Daily Entry Point Trade Alerts - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Health Care Notes: Analysts raise HCA price targets - Nashville Post

Nov 20, 2025
pulisher
Nov 20, 2025

Should I hold or sell Harrow Inc. stock in 2025Portfolio Gains Summary & Risk Managed Investment Entry Signals - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Harrow, Inc. Hits Day High with 7.65% Surge in Strong Intraday Performance - Markets Mojo

Nov 20, 2025
pulisher
Nov 20, 2025

How Harrow Inc. stock performs in rising dollar environment2025 AllTime Highs & Risk Controlled Stock Alerts - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

How Harrow Inc. stock reacts to job market dataJuly 2025 Decliners & Weekly Market Pulse Updates - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What insider trading reveals about Harrow Inc. stockBear Alert & Momentum Based Trading Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Harrow Inc. stock sustain market leadership2025 Price Momentum & AI Enhanced Trading Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Harrow, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:HROW) 2025-11-19 - Seeking Alpha

Nov 19, 2025
pulisher
Nov 19, 2025

How Harrow Inc. stock performs in rate cut cyclesEarnings Risk Summary & High Accuracy Trade Signal Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Harrow officially acquires Melt Pharmaceuticals - Eyes On Eyecare

Nov 19, 2025
pulisher
Nov 19, 2025

Detecting price anomalies in Harrow Inc. with AIJuly 2025 Fed Impact & Consistent Profit Trading Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Harrow's (HROW) Return to Profitability Reshape Its Growth Narrative? - simplywall.st

Nov 19, 2025
pulisher
Nov 19, 2025

Analyzing Harrow Inc. with risk reward ratio charts2025 Biggest Moves & Safe Swing Trade Setups - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Best data tools to analyze Harrow Inc. stockJuly 2025 PostEarnings & Consistent Return Investment Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Harrow Completes Its Acquisition of Melt Pharmaceuticals - VisionMonday.com

Nov 19, 2025
pulisher
Nov 18, 2025

What analysts say about Harrow Inc stockStock Price Targets & Affordable Growth Investments - earlytimes.in

Nov 18, 2025
pulisher
Nov 18, 2025

Will Harrow Inc. stock pay special dividendsMarket Trend Report & Weekly Top Stock Performers List - newser.com

Nov 18, 2025
$37.21
price down icon 1.48%
$21.29
price up icon 0.09%
drug_manufacturers_specialty_generic RDY
$14.02
price down icon 0.50%
$11.65
price up icon 0.52%
$152.80
price down icon 1.26%
$493.99
price up icon 1.12%
Kapitalisierung:     |  Volumen (24h):